OliX Pharmaceuticals, Inc (KOSDAQ:226950)
164,800
+4,000 (2.49%)
Apr 10, 2026, 3:30 PM KST
256.71% (1Y)
| Market Cap | 3.35T +276.9% |
| Revenue (ttm) | 14.67B +158.3% |
| Net Income | -15.74B |
| EPS | -800.46 |
| Shares Out | 20.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 157,384 |
| Average Volume | 318,635 |
| Open | 163,000 |
| Previous Close | 160,800 |
| Day's Range | 159,200 - 169,500 |
| 52-Week Range | 34,500 - 217,000 |
| Beta | 0.56 |
| RSI | 45.96 |
| Earnings Date | Mar 27, 2026 |